UPSTREAM
Phase 2 Unknown
340 enrolled
ALT GIST
Phase 2 Unknown
78 enrolled
InterAACT
Phase 2 Unknown
91 enrolled
A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17
Phase 2 Unknown
251 enrolled
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
Phase 2 Unknown
165 enrolled 15 charts
FB-12
Phase 2 Unknown
64 enrolled
Multicenter Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab, Bendamustine, Gemcitabine, Vinorelbine (Nivo-BeGEV) in Patients With Relapsed/Refractory Hodgkin Lymphoma
Phase 2 Unknown
50 enrolled
Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM
Phase 2 Unknown
64 enrolled
OMNI-Can
Phase 2 Unknown
200,000 enrolled
Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status
Phase 2 Unknown
35 enrolled
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Phase 2 Unknown
63 enrolled 16 charts
Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva
Phase 2 Unknown
57 enrolled 11 charts
MASTERPLAN
Phase 2 Unknown
120 enrolled
DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC
Phase 2 Unknown
60 enrolled
READIT
Phase 2 Unknown
100 enrolled
LungTech
Phase 2 Unknown
39 enrolled
Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer
Phase 2 Unknown
67 enrolled 9 charts
A Phase II Trial of Preoperative Chemotherapy for Biliary Tract Cancer (BTC) With Node Metastasis
Phase 2 Unknown
25 enrolled
P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma.
Phase 2 Unknown
66 enrolled
A Randomized Study of Olanzapine for the Prevention of CINV in Patients Receiving Moderately Emetogenic Chemotherapy
Phase 2 Unknown
58 enrolled
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery
Phase 2 Unknown
165 enrolled
Pharmacokinetic Study of Carboplatin in Pediatric Hematopoietic Stem Cell Transplantation
Phase 2 Unknown
24 enrolled
Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma
Phase 2 Unknown
118 enrolled
Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)
Phase 2 Unknown
30 enrolled
The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).
Phase 2 Unknown
72 enrolled
A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment
Phase 2 Unknown
35 enrolled
Docetaxel and Oxaliplatin Combination With Locally Advanced or Metastatic Biliary Tract Cancer
Phase 2 Unknown
53 enrolled
Lap RC
Phase 2 Unknown
495 enrolled
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Phase 2 Unknown
80 enrolled
CBF(+)AML
Phase 2 Unknown
43 enrolled
Phase II Study in Patients With Operable Breast Cancer
Phase 2 Unknown
30 enrolled
CRC005
Phase 2 Unknown
31 enrolled
A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL
Phase 2 Unknown
37 enrolled
FLAG+Ida With G-CSF Priming for Patients Younger Than 60 Years With Resistant AML
Phase 2 Unknown
37 enrolled
Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma
Phase 2 Unknown
43 enrolled
Fludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AML
Phase 2 Unknown
19 enrolled